Anemia Linkeded With Greater Risk of Death in Heart Disease Patients
Posted on: Friday, 29 May 2009, 07:51 CDT
A new study appearing in Congestive Heart Failure has found that the presence of anemia in patients with chronic heart failure is associated with a significantly increased risk of death. The findings also show that anemia is associated with a poorer degree of left ventricular function and a lower left ventricular ejection fraction, an objective measure of cardiac function.Heart failure is a common and serious chronic illness. A large number of patients with heart failure also have anemia, which is most likely a complication from poor heart function. The aim of this study was to assess the impact of anemia on the clinical outcomes of chronic heart failure (CHF) by a meta-analysis and systemic review of published literature . A total of 97,699 patients with CHF were identified from the published studies. From a collective analysis, researchers found that when anemia occurs, it worsens patient prognosis, making them more likely to be hospitalized or die from heart failure.
“Health professionals may need to improve current practices to better treat anemia in patients with chronic heart failure,” says Dr. Lexin Wang, M.D., Ph.D., Head of the Cardiovascular Group at Charles Sturt University and co-author of the study.
Even with contemporary medical treatment, the mortality rate from chronic heart failure is still very high, reaching 40 percent in very sick patients. Given the clear association between anemia and the mortality rate and hospitalization rate, optimal treatment of anemia, on top of other heart-failure-specific therapies, may reduce the rate of mortality and further improve patient’s prognosis.
Co-Editor’s in Chief, Drs. John Strobeck and Marc Silver are feel that “this publication by Dr. Wang and collaborators give some perspective to nearly a decade of interest on the relationship and role of anemia in patients with chronic heart failure.
------------
On The Net:
Wiley-Blackwell
Related Articles
- Pronova's Phase III Heart Failure Study Meets Endpoint
- St. Jude Medical Announces FDA Approval and Launch of QuickOpt(TM) Timing Cycle Optimization for Heart Failure and ICD Patients; Innovative Feature Addresses 'Non-Optimization' of Device Patients
- Amgen Drug May Decrease Heart Failure Mortality
- Diuretics first line against heart failure: study
- Diuretics first line against heart failure -study
- Research Suggests That Cardiac Marker NT-proBNP is a Better Predictor for Mortality Than BNP in Heart Failure Patients With Reduced Kidney Function
- Heart Failure Society of America's 9th Annual Scientific Meeting Features Progress in Heart Failure Research and Patient Care
- NitroMed Announces Launch of BiDil(R) for the Treatment of Heart Failure in Black Patients
- Vitamin E Supplements Might Increase Heart Failure Risks Forcertain Patients
- Death During Polysomnography of a Patient With Cheyne-Stokes Respiration, Respiratory Acidosis, and Chronic Heart Failure*
Rating: 3.7 / 5 (9 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds